Trevor Bezdek - 02 Nov 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Nov 2025, 19:59:39 UTC
Prior SEC filing
03 Sep 2024
Next SEC filing
10 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gracye Cheng, Attorney-in-Fact for Trevor Bezdek

Key filing fact

Trevor Bezdek filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 03 Nov 2025.

Key facts

  • This page summarizes Trevor Bezdek's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Nov 2025, 19:59.

Change

  • Previous filing in this sequence was filed on 03 Sep 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001822104 Primary reporting owner

Bezdek Trevor

Relationship
Director
Address
C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Trevor Bezdek
Signature date
03 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+33,530
Change %
+26%
Price
$0.000000
Shares after
160,082
Date
02 Nov 2025
Ownership
Direct
Footnotes
F1
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,632,721
Date
02 Nov 2025
Ownership
By TB 2024-2 GRAT
Footnotes
F2
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,632,721
Date
02 Nov 2025
Ownership
By JB 2024-2 GRAT
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GDRX transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+104,925
Change %
Price
$0.000000
Shares after
104,925
Date
02 Nov 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
104,925
Exercise price
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 3, 2026 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.

Footnote F2

Share held directly by TB 2024 -2 GRAT, a grantor retained annuity trust (the "TB 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT.

Footnote F3

Share held directly by JB 2024-2 GRAT, a grantor retained annuity trust (the "JB 2024-2 GRAT"). Jana Bezdek, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the TB 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Footnote F5

The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 2, 2026, subject to continued service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .